SG
IDYA icon

Sankala Group’s IDEAYA Biosciences IDYA Stock Holding History

Sankala Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38K Hold
108
– – ﹤0.01% 462
2025
Q4 		$3.48K Buy
+108
New +$3.44K ﹤0.01% 473

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sankala Group's IDYA Position: Q1 2026 in Review

Sankala Group held its IDEAYA Biosciences (IDYA) position steady in Q1 2026 at 108 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #462.

Sankala Group first reported a position in IDYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.48K in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Sankala Group held 108 shares of IDEAYA Biosciences worth $3.38K as of Q1 2026.
  • Sankala Group left its IDEAYA Biosciences share count unchanged in Q1 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #462 holding.
  • Sankala Group first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Sankala Group's IDEAYA Biosciences position peaked at $3.48K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.